Evidence map›Paper›PMID 32273871›Full record

ArticleFrontiers in microbiology2020

Diversity Profiling of Grapevine Microbial Endosphere and Antagonistic Potential of Endophytic

Jennifer Millera Niem, Regina Billones-Baaijens, Benjamin Stodart, Sandra Savocchia

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 106 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Pea-cucumber crop rotation suppressesFrontiers in microbiology · 2025
    Article
  15. Review
  16. Article
  17. Impact of the Biocontrol Product, EsquiveJournal of fungi (Basel, Switzerland) · 2024
    Article
  18. Genome Analysis ofJournal of fungi (Basel, Switzerland) · 2024
    Article
  19. Article
  20. Microorganisms · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jennifer Millera NiemNational Wine and Grape Industry Centre, Charles Sturt University, Wagga Wagga, NSW, Australia.
Regina Billones-BaaijensNational Wine and Grape Industry Centre, Charles Sturt University, Wagga Wagga, NSW, Australia.
Benjamin StodartSchool of Agricultural and Wine Sciences, Charles Sturt University, Wagga Wagga, NSW, Australia.
Sandra SavocchiaNational Wine and Grape Industry Centre, Charles Sturt University, Wagga Wagga, NSW, Australia.
Charles Sturt University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Grapevine trunk diseases (GTDs) are a serious problem of grapevines worldwide. The microbiota of the grapevine endosphere comprises prokaryotic and eukaryotic endophytes, which may form varied relationships with the host plant from symbiotic to pathogenic. To explore the interaction between grapevine endophytic bacteria and GTDs, the endomicrobiome associated with grapevine wood was characterized using next-generation Illumina sequencing. Wood samples were collected from grapevine trunks with and without external symptoms of GTD (cankers) from two vineyards in the Hunter Valley and Hilltops, NSW, Australia and metagenomic characterization of the endophytic community was conducted using the 16S rRNA gene (341F/806R) and ITS (1F/2R) sequences. Among the important GTD pathogens,

Indexed as

biocontrolBotryosphaeria diebackendophyteEsca/Petri diseaseEutypa diebackmicrobiomePseudomonas poae

Identifiers

PMID32273871
PMCPMC7113392
OpenAlexW3013672497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.